Viewing Study NCT00626704

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 8:00 PM

Ignite Modification Date: 2026-04-08 @ 5:52 AM

Study NCT ID: NCT00626704

Status: COMPLETED

Last Update Posted: 2015-05-25

First Post: 2008-02-14

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma

Sponsor: Amgen

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module